The $BIIB buyout story has put a bid under other key biotech buyout targets like $ACAD. Chart shows a steady accumulation within a bullish channel in a modest uptrend.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
